Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LANDMARK: Lanthanum Carbonate vs Calcium Carbonate in Hemodialysis
NCT01578200Phase 3Completed
- Sponsor
- Translational Research Center for Medical Innovation
- Start
- Dec 2011
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lanthanum carbonate in hyperphosphatemia (2 arms), sponsored by Translational Research Center for Medical Innovation. Primary endpoint: Cardiovascular event free survival time at 3 years. Started Dec 2011; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT01578200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01578200.